Most of the time, stopping does not cause gastrointestinal side effects like when you start
Parenteral Vitamin B12 is the recommended treatment and will be required for the remainder of the patient's life
The 12 mg group achieved 23.7% average weight loss (27.2 kg or 60 pounds), while the 9 mg group lost 20.0%
Duration of use : Suitable for a course of treatment of 1 to 2 months (1 bottle = 30-60 days depending on dosage)
Several methods are introduced to increase the half-life of GLP-1 including: (i) modifying peptides to make them resistant to cleavage by DPP-4, such as exenatide twice daily and lixisenatide, (ii) attaching free fatty acid side chains to liraglutide and semaglutide, which enhances their binding to plasma albumin thereby preventing renal filtration of GLP-1 and prolonging their action in vivo [36, 37], (iii) conjugation of albumin or the Fc fragment of IgG to GLP-1 molecule is used in albiglutide and dulaglutide [37, 38], (iv) development of modified nanoparticles for the controlled release of exenatide-LAR (long-acting release) that provide prolonged release of the peptide [39], and finally, (v) chemical permeation enhancers such as sodium salcaprozate (SNAC) could be utilized to overcome the low permeability and high enzymatic degradation of the gastrointestinal tract of GLP-1 analog that is administrated orally such as semaglutide [40]
